Bioasis Technologies Inc (BTI) - Financial and Strategic SWOT Analysis Review



Bioasis Technologies Inc (BTI) operates as a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company’s transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents across the blood brain barrier. It commercializes its business operations through Cognitest and Transcend names. BTI operates through research institutions and other biotechnology and pharmaceutical companies. The company provides services by conducting research and development with pharmaceutical companies and institutions to advance its technologies. BTI is headquartered in Guilford, Connecticut, the US.

Bioasis Technologies Inc Key Recent Developments

Mar 04,2020: Bioasis announces the appointment of Dr. May Orfali to the Position of Consultant Chief Medical Officer
Dec 04,2019: Bioasis appoints consultant Chief Medical Officer and nominates Medical Oncology Advisory Board
Nov 25,2019: Bioasis announces director resignation
Nov 14,2019: Bioasis announces issuance of Japanese patent relating to xB3 platform technology for the delivery of therapeutic agents across the blood-brain barrier
Sep 10,2019: Bioasis Announces Allowance of Patent Application in Japan Relating to xB3 Platform Technology for the Delivery of Therapeutic Agents Across the Blood-Brain Barrier

This comprehensive SWOT profile of Bioasis Technologies Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Bioasis Technologies Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
 



Section 1 - About the Company

Bioasis Technologies Inc - Key Information
Bioasis Technologies Inc - Overview
Bioasis Technologies Inc - Key Employees
Bioasis Technologies Inc - Key Employee Biographies
Bioasis Technologies Inc - Key Operational Heads
Bioasis Technologies Inc - Major Products and Services
Bioasis Technologies Inc - History
Bioasis Technologies Inc - Company Statement
Bioasis Technologies Inc - Locations And Subsidiaries
Bioasis Technologies Inc
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Bioasis Technologies Inc - Business Description
Bioasis Technologies Inc - Corporate Strategy
Bioasis Technologies Inc - SWOT Analysis
SWOT Analysis - Overview
Bioasis Technologies Inc - Strengths
Bioasis Technologies Inc - Weaknesses
Bioasis Technologies Inc - Opportunities
Bioasis Technologies Inc - Threats
Bioasis Technologies Inc - Key Competitors

Section 3 - Company Financial Performance Charts

Bioasis Technologies Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company
 


List Of Tables



Bioasis Technologies Inc, Key Information
Bioasis Technologies Inc, Key Ratios
Bioasis Technologies Inc, Share Data
Bioasis Technologies Inc, Major Products and Services
Bioasis Technologies Inc, History
Bioasis Technologies Inc, Key Employees
Bioasis Technologies Inc, Key Employee Biographies
Bioasis Technologies Inc, Key Operational Heads
Bioasis Technologies Inc, Other Locations
Bioasis Technologies Inc, Subsidiaries
Bioasis Technologies Inc, Key Competitors
Bioasis Technologies Inc, SWOT Analysis
Bioasis Technologies Inc, Ratios based on current share price
Bioasis Technologies Inc, Annual Ratios
Bioasis Technologies Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 


List Of Figures



Bioasis Technologies Inc, Performance Chart
Bioasis Technologies Inc, Ratio Charts
 


Mind Technologies Inc (MIND) - Financial and Strategic SWOT Analysis Review

MIND Technologies Inc (MIND) is a diversified company. The company designs, manufactures and markets marine sonar and seismic equipment, exploration equipment and specialized equipment. It offers seismic source acquisition and

USD 300 View Report

Theralink Technologies Inc (OBMP) - Financial and Strategic SWOT Analysis Review

Theralink Technologies Inc (Theralink), formerly OncBioMune Pharmaceuticals Inc is a biopharmaceutical company that develops novel cancer immunotherapy products. The companys products comprise biosimilars and vaccines developed for cancer types such

USD 300 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available